) versus P/G + Placebo: (48 ). When thinking about the pCR rate as outlined by the Chevallier classification (major endpoint), no statistically significant distinction was discovered amongst the two remedy groups: F/G + palbociclib: three sufferers (2 ) versus P/G + Placebo: eight individuals (7 ) (p = 0.1464) (Supplementary Table two). Also, per …
Continue reading “) versus P/G + Placebo: (48 ). When considering the pCR rate based on”